*Department of Otorhinolaryngology, and †Department of Internal Medicine, Afyon Kocatepe University, Faculty of Medicine, Afyonkarahisar, Turkey.
Otol Neurotol. 2013 Oct;34(8):1400-4. doi: 10.1097/MAO.0b013e31829b57df.
Idiopathic Sudden sensorineural hearing loss (ISSNHL) is a common otologic emergency. Recently, the cause of ISSNHL, which is still unclear, has been focused on chronic inflammation. Neutrophil-to-lymphocyte ratio (NLR) is a new and quick inflammatory marker, which is being measured routinely in CBC tests without any cost. We aimed to investigate the relationship between ISSNHL and inflammation by using NLR.
Forty-seven patients diagnosed with ISSNHL and 45 age- and sex-matched healthy subjects were enrolled in the study. An automated blood cell counter was used for NLR measurements. The hearing assessments of the patients were carried out by an audiometer, and audiometric patterns were assessed initially and after 1 month of the treatment. All the patients were treated with prednisone in the dose of 1 mg/kg per day, with a progressive dose reduction maintained for at least 2 weeks. Then, the patients were divided into 2 groups as " recovered" and "unrecovered" according to their response to the treatment.
The mean NLR, neutrophil, and lymphocyte values in patients with ISSNHL were significantly higher than the control group (p < 0.001, p < 0.001, and p = 0.004, respectively). In addition, NLR levels were higher in unrecovered patients compared with the recovered ones (p < 0.001).
This is the first study investigating the relationship between NLR levels and ISSNHL and its prognosis. While evaluating ISSNHL, determining NLR should not be overlooked as a quick and reliable indicator for predicting the diagnosis and the prognosis of the disease.
特发性突发性聋(ISSNHL)是一种常见的耳科急症。最近,该病的病因(仍不清楚)一直集中在慢性炎症上。中性粒细胞与淋巴细胞比值(NLR)是一种新的快速炎症标志物,在常规的 CBC 检测中无需额外费用即可测量。我们旨在通过 NLR 研究 ISSNHL 与炎症之间的关系。
本研究纳入了 47 例确诊为 ISSNHL 的患者和 45 名年龄和性别匹配的健康对照者。使用自动血细胞计数器测量 NLR。患者的听力评估由听力计进行,在治疗开始时和治疗后 1 个月进行听力评估。所有患者均接受泼尼松治疗,剂量为 1mg/kg/天,至少持续 2 周逐渐减量。然后,根据治疗反应将患者分为“恢复”和“未恢复”两组。
ISSNHL 患者的平均 NLR、中性粒细胞和淋巴细胞值明显高于对照组(p<0.001、p<0.001 和 p=0.004)。此外,未恢复组患者的 NLR 水平高于恢复组(p<0.001)。
这是首次研究 NLR 水平与 ISSNHL 及其预后之间的关系。在评估 ISSNHL 时,不应忽视 NLR 作为预测疾病诊断和预后的快速可靠指标。